Medtronic Appoints Thierry Pieton

Medtronic (NYSE: MDT) announced today that it appointed Thierry Piéton as its new chief financial officer (CFO), effective ...
Medtronic plc (NYSE:MDT) develops, manufactures and sells device-based medical therapies to health care systems, physicians, clinicians and patients worldwide. It will report its Q3 2025 earnings on ...
Medicare may begin to cover renal denervation with Medtronic’s Symplicity device by October, which could drive coverage among ...
Medtronic appoints Thierry Piéton as CFO, bringing in a seasoned financial leader with experience at Renault Group.
Overall, Medtronic's dividend is safe for now, but there may be better income-generating investments out there to choose from ...
Medtronic (NYSE: MDT) announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical.
Medtronic said the Centers for Medicare & Medicaid Services is opening a coverage analysis on renal denervation for patients with hypertension that will include the review of its medical device. The ...
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...